This elevated LOX expression is associated with larger tumour volumes, advanced clinical stages, lymph node metastasis, and the absence of oestrogen receptor (ER) and progesterone receptor (PR) expression, but it is positively correlated with human epidermal growth factor receptor 2 (HER2) positivity 35. Here, PGR is linked to neoplasm.